Jacquie Astemborski
Overview
Explore the profile of Jacquie Astemborski including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
93
Citations
3236
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Baker P, Genberg B, Astemborski J, Mehta S, Kirk G, Cepeda J
Drug Alcohol Rev
. 2024 Jul;
43(7):1859-1864.
PMID: 38951716
Introduction: Given structural barriers, access to services is key for preventing drug-related harms and managing chronic disease among people who inject drugs (PWID). The Patient Activation Measure (PAM), a validated...
2.
Grudda T, Thomas D, Kirk G, Mehta S, Astemborski J, Lauer G, et al.
J Infect Dis
. 2024 May;
230(6):1352-1356.
PMID: 38779916
After recovery from a hepatitis B virus (HBV) infection, reactivation can occur with immunosuppression; thus, it is assumed that replication competent HBV persists in the liver. We sought to detect...
3.
Coyle C, Gicquelais R, Genberg B, Astemborski J, Falade-Nwulia O, Kirk G, et al.
Drug Alcohol Depend
. 2024 Mar;
253.
PMID: 38456165
Background: Although hepatitis C virus (HCV) can be cured by direct acting antivirals (DAA), uptake is not well characterized for people who inject drugs (PWID). Methods: Among 1,130 participants of...
4.
Rudolph J, Cepeda J, Astemborski J, Kirk G, Mehta S, German D, et al.
Int J Drug Policy
. 2024 Feb;
126:104364.
PMID: 38408416
Background: Overdoses involving opioids and stimulants are on the rise, yet few studies have examined longitudinal trends in use of both substances. We sought to describe use and co-use of...
5.
Tewari S, Kirk G, Arking D, Astemborski J, Newcomb C, Piggott D, et al.
Sci Rep
. 2023 Oct;
13(1):18406.
PMID: 37891237
We evaluated the prospective association of mitochondrial DNA copy number (mtDNA CN) with markers of kidney function among a cohort of persons who inject drugs (PWID). This is a Prospective...
6.
Baker P, Cepeda J, Schluth C, Astemborski J, Feder K, Rudolph J, et al.
Prev Med Rep
. 2023 Oct;
36:102448.
PMID: 37840593
People who inject drugs (PWID) may have diminished access to essential preventive services like COVID-19 vaccination given structural and substance use barriers. We aimed to assess the role of HIV...
7.
Patel E, Mehta S, Genberg B, Baker O, Schluth C, Astemborski J, et al.
Drug Alcohol Depend Rep
. 2023 Aug;
8:100184.
PMID: 37637232
Background: SARS-CoV-2 serosurveys can help characterize disparities in SARS-CoV-2 infection and identify gaps in population immunity. Data on SARS-CoV-2 seroprevalence among people who inject drugs (PWID) are limited. Methods: We...
8.
Rudolph J, Cepeda J, Astemborski J, Kirk G, Mehta S, Genberg B
Int J Drug Policy
. 2023 Jul;
118:104120.
PMID: 37429162
Background: Medication for opioid use disorder (MOUD) is an effective intervention to combat opioid use disorder and overdose, yet there is limited understanding of engagement in treatment over time in...
9.
Coyle C, Desjardins M, Curriero F, Rudolph J, Astemborski J, Falade-Nwulia O, et al.
J Viral Hepat
. 2023 Jun;
30(10):810-818.
PMID: 37382024
We evaluated geographic heterogeneity in hepatitis C virus (HCV) treatment penetration among people who inject drug (PWID) across Baltimore, MD since the advent of direct-acting antivirals (DAAs) using space-time clusters...
10.
Artenie A, Stone J, Fraser H, Stewart D, Arum C, Lim A, et al.
Lancet Gastroenterol Hepatol
. 2023 Mar;
8(6):533-552.
PMID: 36996853
Background: Measuring the incidence of HIV and hepatitis C virus (HCV) infection among people who inject drugs (PWID) is key to track progress towards elimination. We aimed to summarise global...